首页> 外文期刊>Open medicine >Financial burden of household out-of-pocket expenditures for prescription drugs: Cross-sectional analysis based on national survey data
【24h】

Financial burden of household out-of-pocket expenditures for prescription drugs: Cross-sectional analysis based on national survey data

机译:家庭处方药家庭自付费用的财务负担:基于国家调查数据的横断面分析

获取原文
获取外文期刊封面目录资料

摘要

BackgroundCommentaries on the adequacy of insurance coverage for prescription drugs available to Canadians have emphasized differences in the coverage provided by different provincial governments. Less is known about the actual financial burden of prescription drug spending and how this burden varies by province of residence, affluence and source of primary drug coverage.MethodsWe used data from a nationally representative household expenditure survey to analyze the financial burden of prescription drugs. We focused on the drug budget share (defined as the share of the household budget spent on prescription drugs), considering how it varied by province, total household budget and likely primary source of drug insurance coverage (i.e., provincial government plan for senior citizens, social assistance plan or private coverage). We examined both “typical” households (at the median of the distribution of the drug budget share) and households with relatively large shares (in the top 5%). Finally, we estimated the percentage of households with catastrophic drug expenditures (defined as a drug budget share of 10% or more) and the average catastrophic drug expenditures.ResultsSenior, social assistance and general population households accounted for 21.1%, 8.9% and 69.9% of the sample of 14 430 respondents to the 2006 Survey of Household Spending, respectively. The median drug budget share in Canada was 1.1% for senior households (range 0.4% [Ontario] to 3.6% [Saskatchewan]) and 0.1% for both social assistance households and general population households, with little appreciable variation across provinces for these latter 2 categories. The 95th percentile drug budget share in Canada was 7.4% for senior households (range 3.5% [Ontario] to 12.7% [Saskatchewan]), 5.4% for social assistance households (range 2.3% [British Columbia] to 13.0% [Prince Edward Island]) and 2.6% for general population households (range 2.1% [Ontario] to 5.4% [Prince Edward Island]). The interprovincial range of the 95th percentile drug budget share was 10.7 percentage points for social assistance households, 9.2 percentage points for senior households and 3.3 percentage points for general population households.InterpretationFor most households, the financial burden of prescription drug expenditures appeared to be relatively small, with little interprovincial variation. However, a small number of households incurred catastrophic drug costs. These households were concentrated in the groups that traditionally benefit from provincial government drug plans. It is likely that some households did not purchase needed prescription drugs because of the expense, so our estimates of the financial burden of catastrophic prescription drug expenditures therefore represent a lower bound.
机译:背景关于加拿大人可获得的处方药保险范围是否足够的评论,强调了不同省政府提供的保险范围的差异。对于处方药支出的实际财务负担以及该负担如何因居住省份,富裕程度和主要药品覆盖范围而变化的情况知之甚少。方法我们使用来自全国代表性的家庭支出调查的数据来分析处方药的财务负担。考虑到各省,家庭总预算和可能的主要药物保险来源(即省政府针对老年人的计划,社会救助计划或私人保险)。我们同时检查了“典型”家庭(以药物预算份额分配的中位数)和份额较大的家庭(前5%)。最后,我们估算了灾难性药物支出家庭(定义为药物预算份额为10%或更高)的百分比和平均灾难性药物支出。结果老年人,社会救助和一般人口家庭分别占21.1%,8.9%和69.9%分别来自2006年家庭支出调查的14430名受访者的样本。在加拿大,高级家庭的药品预算中位数份额为1.1%(从安大略省的0.4%到萨斯喀彻温省的3.6%)和社会救助家庭和普通居民家庭的0.1%,这两个省份在各省之间差异不大类别。加拿大第95个百分位数的药品预算份额为:高级家庭为7.4%(安大略省为3.5%至萨斯喀彻温省为12.7%),社会援助家庭为5.4%(不列颠哥伦比亚省为2.3%至13.0%(爱德华王子岛) ])和普通居民家庭的2.6%(范围从2.1%[安大略省]到5.4%[爱德华王子岛])。在第95个百分位数的药品预算份额中,跨省份的范围是社会援助家庭为10.7个百分点,老年家庭为9.2个百分点,普通人口家庭为3.3个百分点解释对于大多数家庭来说,处方药支出的财务负担似乎相对较小,省际差异很小。但是,少数家庭产生了灾难性的药品费用。这些家庭集中在传统上受益于省政府毒品计划的人群中。某些家庭可能会因为费用而没有购买所需的处方药,因此我们对灾难性处方药支出的财务负担的估计值较低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号